aTyr Pharma Announces Third Quarter 2025 Results and Provides Corporate Update

Results reported for Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary sarcoidosis. Company plans to meet with the FDA to ...
Healio

Odds for mortality in COPD exacerbation hospitalization lower with prior bariatric surgery

Patients hospitalized for acute COPD exacerbation had reduced odds for in-hospital mortality if they had a prior history of bariatric surgery, according to data presented at the CHEST Annual Meeting.“ ...
Canadian Medical Association Journal

Intermediate–high-risk pulmonary embolism in a 53-year-old woman with colorectal cancer and contraindication to thrombolysis

Key points A 53-year-old woman with rectosigmoid adenocarcinoma was seen in the radiation oncology clinic for her fifth and final fraction of neoadjuvant radiotherapy, where she reported chills, ...
European Medical Journal

AI-Driven Identification of High-Risk Patients with COPD for Biologic Therapy: Pathway Development Opportunities

Biologic therapies targeting eosinophilic inflammation hold promise for COPD management. Realising their benefits will ...